Dihexa has a long half-life (approximately 12 days), so effects are cumulative and build over time
To date, MSCs have been extensively utilized in both preclinical and clinical investigations of various diseases, including lupus erythematosus, Sjgrens syndrome, inflammatory bowel disease, and graft-versus-host disease
Common side effects include injection site pain or swelling, temporary dehydration, nausea with rapid administration, dizziness, and gastrointestinal upset
Adequate glutathione availability remains critical for maintaining health and promoting longevity
First, phase II clinical trials evaluating MOTS-c in type 2 diabetes and sarcopenia are in development, and their results will provide the first randomized controlled evidence in humans to define therapeutic doses with statistical rigor
Until you know the root cause of any illness, BPC-157 may help with healing, but underlying health issues may continue to cause damage